Connect Biopharma Holdings logo

CNTB - Connect Biopharma Holdings News Story

$22.1 0.1  0.5%

Last Trade - 28/07/21

Sector
Healthcare
Size
Mid Cap
Market Cap £884.3m
Enterprise Value £1.11bn
Revenue £n/a
Position in Universe 2686th / 7000

BRIEF-Connect Biopharma Completes Enrollment Of CBP-201 Global Phase 2 Clinical Trial

Thu 8th April, 2021 1:22pm
April 8 (Reuters) - Connect Biopharma Holdings Ltd  CNTB.O :
    * CONNECT BIOPHARMA COMPLETES ENROLLMENT OF CBP-201 GLOBAL
PHASE 2
CLINICAL TRIAL IN MODERATE-TO-SEVERE ATOPIC DERMATITIS
    * CONNECT BIOPHARMA HOLDINGS LIMITED - RESULTS FROM GLOBAL
PHASE 2
CLINICAL TRIAL EXPECTED IN SECOND HALF OF 2021

Source text for Eikon:  ID:nGNX8wchxC 
Further company coverage:  CNTB.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.